Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SYNAPTICS IncSYNA · Entity 4089 | SVP of Worldwide Sales | November 14, 2016 | November 15, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SYNAPTICS Inc
Report date November 14, 2016 · Filed November 15, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,358 |
Ending reported balance
After 2016-11-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-11-14 · Exercise / conversion · Acquired 983 · Balance 15,341 Row 2 · 2016-11-14 · Sale · Disposed 983 · Balance 14,358 F1: The shares were sold pursuant to a 10b5-1 Trading Plan dated August 1, 2016. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.50 · Expires 2020-10-28 | Direct | 0 |
Reported balance
After 2016-11-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-11-14 · Exercise / conversion · Disposed 983 · Balance 0 F2: 1/12th of the total number of shares subject to the options vested and became exercisable each quarter following the October 28, 2013 grant date, until fully vested on October 28, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold pursuant to a 10b5-1 Trading Plan dated August 1, 2016.
F2: 1/12th of the total number of shares subject to the options vested and became exercisable each quarter following the October 28, 2013 grant date, until fully vested on October 28, 2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2016 Filed Nov 15, 2016 23:44 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 983 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001209191-16-150312 · doc4.xml · derivative · entry 3 Deutsch Scott · CIK 0001548131 · SVP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 983 shares Expires 2020-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the options vested and became exercisable each quarter following the October 28, 2013 grant date, until fully vested on October 28, 2016. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 23:44 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 983 | $56.50 | $55,539.50 |
DisclosureSEC source: 0001209191-16-150312 · doc4.xml · nonDerivative · entry 2 Deutsch Scott · CIK 0001548131 · SVP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,358 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated August 1, 2016. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 23:44 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 983 | $46.50 | $45,709.50 |
DisclosureSEC source: 0001209191-16-150312 · doc4.xml · nonDerivative · entry 1 Deutsch Scott · CIK 0001548131 · SVP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 23:39 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 313 | $52.12 | $16,313.56 |
DisclosureSEC source: 0001209191-16-147735 · doc4.xml · nonDerivative · entry 4 Deutsch Scott · CIK 0001548131 · SVP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,358 F5 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 23:39 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 835 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-147735 · doc4.xml · nonDerivative · entry 3 Deutsch Scott · CIK 0001548131 · SVP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,671 F4 · shares: Reflects shares released October 31, 2016 in connection with the vesting of performance-based market stock units granted on October 28, 2013. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 23:39 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 751 | $52.12 | $39,142.12 |
DisclosureSEC source: 0001209191-16-147735 · doc4.xml · nonDerivative · entry 2 Deutsch Scott · CIK 0001548131 · SVP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,836 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 23:39 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,575 | $0.00 Strike: $52.57 | $0.00 |
DisclosureSEC source: 0001209191-16-147735 · doc4.xml · derivative · entry 5 Deutsch Scott · CIK 0001548131 · SVP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,575 Underlying: Common Stock · 4,575 shares Expires 2023-10-28 F6 · derivative.exercise_date: 33% of the total number of shares subject to the option shall vest and become exercisable one year following the vesting commencement date of 10/28/2016, with the remaining 2/3rds vesting quarterly until fully vested on October 28, 2019. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 23:39 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 7,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-147735 · doc4.xml · nonDerivative · entry 1 Deutsch Scott · CIK 0001548131 · SVP of Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,587 F1 · shares: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of 10/31/2016, until fully vested on 10/31/2019. F2 · balance_after: Includes 189 shares acquired under the Issuer's employee stock purchase plan in May 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.